Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth
- 13 June 2008
- journal article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Myostatin Directly Regulates Skeletal Muscle FibrosisJournal of Biological Chemistry, 2008
- Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitorsProceedings of the National Academy of Sciences, 2008
- Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of ImmunosuppressionMolecular Therapy, 2007
- A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote DogsPLoS Genetics, 2007
- Gene therapy progress and prospects: Hydrodynamic gene deliveryGene Therapy, 2006
- Muscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibitionJournal of Clinical Investigation, 2006
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheepNature Genetics, 2006
- Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelBlood, 2005
- Myostatin Mutation Associated with Gross Muscle Hypertrophy in a ChildNew England Journal of Medicine, 2004